Corporate Banner
Satellite Banner
Technology Networks Header
Friday, September 19, 2014
 
Register | Sign in
Home Page>Products
  Product News
High Throughput Biological Sample Concentrator
Tuesday, September 16, 2014
The miVac Quattro from Genevac is the perfect workhorse sample concentrator for biological laboratories tasked with handling larger numbers of samples.

Lonza Celebrates the 30th Anniversary of Clonetics™ Products, the Pioneer of Primary Cells
Tuesday, September 16, 2014
The Clonetics™ Primary Cells and Media product line supports cell culture research in many areas including angiogenesis, cancer, respiratory and cardiovascular disease, diabetes, renal disorders, and neurobiology.

Medimetrics Expands Medical Device Portfolio with New Fast Release IntelliCap
Tuesday, September 16, 2014
The Company wins ISO and EN Certification for its design & development capabilities.

Dolomite To Launch Meros Tcu-100 Temperature Controller
Monday, September 15, 2014
Meros Tcu-100 Temperature Controller will be launched at the Lab-on-a-Chip & Microarray World Congress.

Tute Genomics Launches MyGene Portal for Genome-guided Medicine
Saturday, September 13, 2014
Selected to showcase healthcare innovation at TEDMED The Hive.

Claritas Genomics Launches Next Generation Sequencing Panel
Saturday, September 13, 2014
ClariFocus Panel to detect genetic causes of nephrotic syndrome in children.

Routine CHN Microanalysis of Difficult Sample Types
Friday, September 12, 2014
CHN microanalysis methodologies for handling volatile liquids, air sensitive compounds and refractory materials.

New Application Note for TAP’s ambr15 Micro Bioreactors
Friday, September 12, 2014
Provides tips on how to maximize data collection with minimum sample volume and smart sampling regimes.

Quickly Identify Rhodamine B in Cosmetics
Friday, September 12, 2014
Determination of Rhodamine B using a rapid separation liquid chromatography column.

<< 1 2 3 4 5 6 7 >>
Showing Results 11 - 20 of 10496
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv